サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1417550

バイオシミュレーション市場レポート：2030年までの動向、予測、競合分析

Biosimulation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

バイオシミュレーション市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

バイオシミュレーションの動向と予測

世界のバイオシミュレーション市場は、2024年から2030年までのCAGRが13.5%で、2030年までに推定68億米ドルに達すると予測されます。この市場の主な促進要因は、バイオシミラーおよび生物製剤の市場拡大、バイオシミュレーションソフトウェアを使用する規制機関の増加、バイオテクノロジーおよび製薬部門における研究開発費の増加です。世界のバイオシミュレーション市場の将来は、製薬・バイオテクノロジー企業、CRO、規制当局、学術研究機関の各市場における機会によって有望視されています。

バイオシミュレーション市場の洞察

Lucintel社は、高度なソフトウェアの利用を奨励する政府の取り組みが増加していることから、予測期間中は医薬品開発が引き続き大きなセグメントを占めると予測しています。

北米は、主要プレイヤーの存在、ヘルスケアのデジタル化の進展、慢性的な健康不安の高まりにより、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.世界のバイオシミュレーション市場は、2030年までに推定68億米ドルに達する見込みです。

Q2.市場の成長予測は？

A2.世界のバイオシミュレーション市場は、2024年から2030年にかけて13.5%のCAGRで成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、バイオ後続品ーおよびバイオ医薬品市場の拡大、バイオシミュレーションソフトウェアを使用する規制機関の増加、バイオテクノロジーおよび製薬部門における研究開発費の増加です。

Q4.市場の主要セグメントは？

A4.バイオシミュレーション市場の将来性は、製薬・バイオテクノロジー企業、CRO、規制当局、学術研究機関の各市場における機会により有望視されています。

Q5.市場の主要企業は？

A5.バイオシミュレーションの主要企業の一部を以下に示します。

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、洗練されたソフトウェアの使用を奨励する政府の取り組みが増加していることから、予測期間中も医薬品開発がより大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、主要プレイヤーの存在、ヘルスケアのデジタル化の進展、慢性的な健康不安の高まりにより、予測期間中も最大地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオシミュレーション市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のバイオシミュレーション市場動向（2018-2023）と予測（2024-2030）
  • デリバリーモデル別の世界のバイオシミュレーション市場
    • サブスクリプションモデル
    • 所有権モデル
  • 製品別の世界のバイオシミュレーション市場
    • ソフトウェア
    • サービス
  • アプリケーション別の世界のバイオシミュレーション市場
    • 医薬品開発
    • 創薬
    • その他
  • 最終用途別の世界のバイオシミュレーション市場
    • 製薬とバイオテクノロジー企業
    • CRO
    • 規制当局
    • 学術調査機関

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のバイオシミュレーション市場
  • 北米のバイオシミュレーション市場
  • 欧州のバイオシミュレーション市場
  • アジア太平洋のバイオシミュレーション市場
  • その他地域のバイオシミュレーション市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 配信モデル別の世界のバイオシミュレーション市場の成長機会
    • 製品別の世界のバイオシミュレーション市場の成長機会
    • アプリケーション別の世界のバイオシミュレーション市場の成長機会
    • 最終用途別の世界のバイオシミュレーション市場の成長機会
    • 地域別の世界のバイオシミュレーション市場の成長機会
  • 世界のバイオシミュレーション市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のバイオシミュレーション市場の能力拡大
    • 世界のバイオシミュレーション市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata
目次

Biosimulation Trends and Forecast

The future of the global biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software, and growing R&D expenditures in the biotechnology and pharmaceutical sectors.

A more than 150-page report is developed to help in your business decisions.

Biosimulation by Segment

The study includes a forecast for the global biosimulation by delivery model, product, application, end use, and region.

Biosimulation Market by Delivery Model [Shipment Analysis by Value from 2018 to 2030]:

  • Subscription Models
  • Ownership Models

Biosimulation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Software
  • Services

Biosimulation Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Development
  • Drug Discovery
  • Others

Biosimulation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Regulatory Authorities
  • Academic Research Institutions

Biosimulation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biosimulation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities aCROss the value chain. With these strategies biosimulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biosimulation companies profiled in this report include-

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Biosimulation Market Insights

Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Features of the Global Biosimulation Market

Market Size Estimates: Biosimulation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biosimulation market size by various segments, such as by delivery model, product, application, end use, and region in terms of value ($B).

Regional Analysis: Biosimulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different delivery model, product, application, end use, and regions for the biosimulation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biosimulation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biosimulation market size?

Answer: The global biosimulation market is expected to reach an estimated $6.8 billion by 2030.

Q2. What is the growth forecast for biosimulation market?

Answer: The global biosimulation market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biosimulation market?

Answer: The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software and increasing r&d expenditures in the biotechnology and pharmaceutical sectors.

Q4. What are the major segments for biosimulation market?

Answer: The future of the biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research institution markets.

Q5. Who are the key biosimulation market companies?

Answer: Some of the key biosimulation companies are as follows.

  • Certara
  • Dassault
  • Advanced Chemistry Development
  • Simulation
  • Schrodinger
  • Chemical Computing Group
  • Physiomics
  • Rosa & Co
  • BioSimulation Consulting
  • Genedata

Q6. Which biosimulation market segment will be the largest in future?

Answer: Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

Q7. In biosimulation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biosimulation market by delivery model (subscription models and ownership models), product (software and services), application (drug development, drug discovery, and others), end use (pharmaceutical & biotechnology companies, CROs, regulatory authorities, and academic research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biosimulation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biosimulation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biosimulation Market by Delivery Model
    • 3.3.1: Subscription Models
    • 3.3.2: Ownership Models
  • 3.4: Global Biosimulation Market by Product
    • 3.4.1: Software
    • 3.4.2: Services
  • 3.5: Global Biosimulation Market by Application
    • 3.5.1: Drug Development
    • 3.5.2: Drug Discovery
    • 3.5.3: Others
  • 3.6: Global Biosimulation Market by End Use
    • 3.6.1: Pharmaceutical & Biotechnology Companies
    • 3.6.2: CROs
    • 3.6.3: Regulatory Authorities
    • 3.6.4: Academic Research Institutions

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biosimulation Market by Region
  • 4.2: North American Biosimulation Market
    • 4.2.1: North American Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.2.2: North American Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.3: European Biosimulation Market
    • 4.3.1: European Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.3.2: European Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.4: APAC Biosimulation Market
    • 4.4.1: APAC Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.4.2: APAC Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
  • 4.5: ROW Biosimulation Market
    • 4.5.1: ROW Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
    • 4.5.2: ROW Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biosimulation Market by Delivery Model
    • 6.1.2: Growth Opportunities for the Global Biosimulation Market by Product
    • 6.1.3: Growth Opportunities for the Global Biosimulation Market by Application
    • 6.1.4: Growth Opportunities for the Global Biosimulation Market by End Use
    • 6.1.5: Growth Opportunities for the Global Biosimulation Market by Region
  • 6.2: Emerging Trends in the Global Biosimulation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biosimulation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biosimulation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Certara
  • 7.2: Dassault
  • 7.3: Advanced Chemistry Development
  • 7.4: Simulation
  • 7.5: Schrodinger
  • 7.6: Chemical Computing Group
  • 7.7: Physiomics
  • 7.8: Rosa & Co
  • 7.9: BioSimulation Consulting
  • 7.10: Genedata